Cargando…
Once-daily tasimelteon (VEC-162) for jet lag following transmeridian travel: A multicenter, randomized, double-blind, placebo-controlled trial
Jet Lag Disorder is a Circadian Rhythm Sleep-Wake Disorder resulting from a misalignment of the endogenous circadian clock and the sleep and wake pattern required by a change in time zone. Jet lag is most severe following eastward travel. This multicenter, randomized, placebo-controlled clinical tri...
Autores principales: | Polymeropoulos, Christos M., Polymeropoulos, Vasilios M., Czeisler, Emily L., Fisher, Michaela A., Smieszek, Sandra P., Xiao, Changfu, Birznieks, Gunther, Polymeropoulos, Mihael H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521676/ https://www.ncbi.nlm.nih.gov/pubmed/36188367 http://dx.doi.org/10.3389/fneur.2022.901467 |
Ejemplares similares
-
Efficacy of Tasimelteon (HETLIOZ®) in the Treatment of Jet Lag Disorder Evaluated in an 8-h Phase Advance Model; a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Polymeropoulos, Christos M., et al.
Publicado: (2020) -
Simulated driving performance in healthy adults after night‐time administration of 20 mg tasimelteon
por: Torres, Rosarelis, et al.
Publicado: (2021) -
Tasimelteon safely and effectively improves sleep in Smith–Magenis syndrome: a double-blind randomized trial followed by an open-label extension
por: Polymeropoulos, Christos M., et al.
Publicado: (2021) -
Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a case study
por: Smieszek, Sandra P., et al.
Publicado: (2023) -
Elevated plasma levels of CXCL16 in severe COVID-19 patients
por: Smieszek, Sandra P., et al.
Publicado: (2022)